Regeneron Pharmaceuticals today announced financial results for the fourth quarter and full year 2024 and provided a business ...

US pharma giant Pfizer reported financial results for fourth-quarter and full-year 2024 and reaffirmed its 2025 financial ...

German biotech Akribion Therapeutics has emerged from stealth with 8 million euros ($9 million) in seed funding to accelerate ...

AdvanCell announced the successful completion of an oversubscribed $112 million (US) Series C financing, making it the only ...

Sionna Therapeutics hopes to raise $150 million and secure a market capitalization of about $692 million in an initial public ...

Eleva, a German biopharmaceutical company, and 3PBIOVIAN, a global contract development and manufacturing organization (CDMO) ...

Russia is experiencing a sharp growth in the demand for drugs against diabetes this year, particular those that are also used ...

US President Donald Trump has implemented a series of tariffs on imports from Canada, Mexico and China, but the additional ...

Japan’s ASKA Pharmaceutical Holdings announced it has decided to acquire additional shares of Vietnam-based Ha Tay ...

French drugmaker Mitem Pharma, which is dedicated to drugs of major therapeutic interest (DMTI), today revealed that has ...

US pharma giant Merck & Co opened Tuesday’s trading 10% lower after announcing its annual and fourth quarter financial results, along with its guidance for 2025.

A Feature on M&A, VC investment licensing and partnerships focusing on novel targets in autoimmune diseases. The global ...